Company: INDP
Filing Date: 2025-06-23
Form Type: DEF 14A
Source: 0001641172-25-016071
Chunk: 4

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-06-23
Form: DEF 14A
Chunk 4
---
 at the Special Meeting if you desire to do so, as your proxy is revocable at your option.

By Order of the Board of Directors

| /s/ Roger J. Pomerantz             |
| Roger J. Pomerantz, M.D., F.A.C.P. |
| Chairman                           |

New York, New York

June 23, 2025

<div align='center'>1

INDAPTUS THERAPEUTICS, INC.

3 Columbus Circle, 15 thFloor

New York, NY 10019

PROXY STATEMENT</div>

This proxy statement is furnished in connection
with the solicitation by the Board of Directors (the “Board” or “Board of Directors”) of Indaptus Therapeutics,
Inc. of proxies to be voted at our Special Meeting of Stockholders to be held on July 25, 2025 (the “Special Meeting”), at
10:00 a.m. Eastern time, at the offices of Indaptus Therapeutics, Inc., 3 Columbus Circle, 15th Floor, New York, NY, and at any continuation,
postponement, or adjournment of the Special Meeting.

Holders of record of shares of our common stock,
$0.01 par value per share, as of the close of business on June 16, 2025 (the “Record Date”), will be entitled to notice of
and to vote at the Special Meeting and any continuation, postponement, or adjournment of the Special Meeting. As of the Record Date,
there were 16,034,444 shares of common stock outstanding and entitled to vote at the Special Meeting. Each share of common stock
is entitled to one vote on any matter presented to stockholders at the Special Meeting.

This proxy statement will be released on or about
July 1, 2025 to our stockholders on the Record Date.

In this proxy statement, “Indaptus”,
“Company”, “we”, “us”, and “our” refer to Indaptus Therapeutics, Inc. (formerly Intec
Parent, Inc.) and, where appropriate, its consolidated subsidiaries, Intec Pharma Ltd. and Decoy Biosystems, Inc. References to “Intec
Parent” refer to Intec Parent, Inc., the successor of Intec Pharma Ltd. following the domestication merger (the “Domestication
Merger”) with Intec Parent, references to “Intec Israel” refer to Intec Pharma Ltd., the